Kassiou; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kassiou; Michael.The latest application filed is for "adamantanyl-substituted benzamide compounds and their use as p2x7 receptor antagonists".

Company Profile

5.7.13

Kassiou; Michael - New South Wales AU
Kassiou; Michael - Lugamo AU
Kassiou; Michael - Lugarno AU
KASSIOU; Michael - The University of Sydney AU
Kassiou; Michael - Bexley AU
Kassiou; Michael - Marrickville AU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Metabolite inspired selective oxytocin receptor agonists Grant 11,414,459 - Kassiou , et al. August 16, 2	2022-08-16
Adamantanyl-substituted Benzamide Compounds And Their Use As P2x7 Receptor Antagonists App 20210323910 - Kassiou; Michael ; et al.	2021-10-21
Therapeutic compounds and compositions for treating social disorders and substance use disorders Grant 11,033,555 - McGregor , et al. June 15, 2	2021-06-15
Synthesis Of Phytocannabinoids Including A Demethylation Step App 20210163438 - Reekie; Tristan ; et al.	2021-06-03
Anti-cancer Compounds App 20210094915 - KASSIOU; Michael ; et al.	2021-04-01
Synthesis of phytocannabinoids including a decarboxylation step Grant 10,807,931 - Reekie , et al. October 20, 2	2020-10-20
Anti-cancer compounds Grant 10,745,355 - Munoz , et al. A	2020-08-18
Metabolite Inspired Selective Oxytocin Receptor Agonists App 20200255475 - Kind Code	2020-08-13
Synthesis Of Phytocannabinoids Including A Decarboxylation Step App 20200172459 - Reekie; Tristan ; et al.	2020-06-04
Non-peptide Oxytocin Receptor Agonists App 20200000823 - KASSIOU; Michael ; et al.	2020-01-02
Therapeutic Compounds And Compositions For Treating Social Disorders And Substance Use Disorders App 20190290658 - MCGREGOR; Iain Stewart ; et al.	2019-09-26
Anti-cancer Compounds App 20180273478 - Munoz; Lenka ; et al.	2018-09-27
Translocator Protein Ligands App 20130224114 - KASSIOU; Michael ; et al.	2013-08-29
Translocator protein ligands Grant 8,492,379 - Kassiou , et al. July 23, 2	2013-07-23
2-arylpyrazolo[l,5-alpha]pyrimidin-3-yl Acetamide Derivatives As Ligands For Translocator Protein (18 Kda) App 20120189548 - Kassiou; Michael ; et al.	2012-07-26
Novel Compounds And Their Uses In Diagnosis App 20110142757 - Kassiou; Michael ; et al.	2011-06-16
Translocator Protein Ligands App 20110044898 - Kassiou; Michael ; et al.	2011-02-24
2-Arylpyrazolo[L,5-Alpha] Pyrimidin-3-YL Acetamide Derivatives as Ligands for Translocator Protein (18 Kda) App 20090311176 - Kassiou; Michael ; et al.	2009-12-17
Radiolabeled pyridyl-7-azabicyclo[2,2,1]heptanes Grant 5,969,144 - London , et al. October 19, 1	1999-10-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.